TD Cowen Maintains Hold on Ginkgo Bioworks Holdings, Raises Price Target to $11
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
TD Cowen analyst Brendan Smith maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Hold and raises the price target from $9 to $11.
TD Cowen analyst Brendan Smith maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Hold and raises the price target from $9 to $11.